| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.95M | 3.73M | 2.88M | 4.82M | 1.81M |
| Gross Profit | 3.95M | 847.49K | 1.41M | 3.03M | -6.79M |
| EBITDA | 1.85M | 1.89M | 1.18M | 3.09M | -7.15M |
| Net Income | 2.22M | 2.03M | 1.51M | 3.48M | -4.53M |
Balance Sheet | |||||
| Total Assets | 132.48M | 115.06M | 105.58M | 119.00M | 140.08M |
| Cash, Cash Equivalents and Short-Term Investments | 10.04M | 1.82M | 9.79M | 14.90M | 20.84M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.79M | 772.46K | 982.68K | 123.75K | 20.47M |
| Stockholders Equity | 126.69M | 114.29M | 104.59M | 118.88M | 119.61M |
Cash Flow | |||||
| Free Cash Flow | -1.37M | 1.24M | 1.56M | -7.92M | -8.62M |
| Operating Cash Flow | -1.37M | 1.24M | 1.56M | -7.92M | -8.62M |
| Investing Cash Flow | 18.88M | -790.81K | 732.04K | -18.61M | 2.56M |
| Financing Cash Flow | -9.29M | -8.42M | -7.40M | 20.59M | 9.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$64.02M | 7.05 | 32.22% | 6.39% | 22.67% | 19.47% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ― | -163.64 | 1.84% | 5.35% | -12.06% | 11.48% | |
61 Neutral | AU$62.22M | -39.84 | 3.57% | 6.89% | 30.36% | -31.47% | |
55 Neutral | AU$26.98M | 70.25 | 2.17% | 2.94% | 38.32% | ― | |
53 Neutral | AU$30.12M | 53.68 | 2.42% | 2.03% | 18.17% | ― |
Ryder Capital reported a strong finish to 2025, with pre-tax net tangible assets rising 3.27% in December to $2.2476 per share despite a $4.8m tax payment, and delivering a 61.03% pre-tax return for the calendar year, significantly ahead of its performance hurdle. Gains were driven by core long-term holdings such as Lumos Diagnostics, Macmahon Holdings, Janison Education and Symal Group, while positions in OFX Group and Vitrafy Life Sciences modestly detracted. The manager actively rebalanced the portfolio, adding to Adore Beauty and Airtasker, backing a capital raise for Polymetals, and fully exiting Humm Group on governance grounds, leaving gross assets at $189.38m and cash at 12.06% of the portfolio. In a move aimed at delivering more regular income and enhancing the appeal of the stock to income-focused investors, Ryder also declared its first quarterly fully franked dividend of 3.0 cents per share under a new enhanced dividend policy, implying an annualised 12.0 cents and a fully franked yield of about 6.2% based on the month-end share price.
The most recent analyst rating on (AU:RYD) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Ryder Capital Ltd. stock, see the AU:RYD Stock Forecast page.
Ryder Capital Limited has declared its first quarterly dividend of 3.0 cents per share fully franked, payable on 27 January 2026, inaugurating a new schedule of quarterly distributions. Under the enhanced dividend policy, the company plans to pay 3.0 cents per share fully franked after each of the March and June quarters of FY26, equating to an annualised 12.0 cents per share, which is intended to form the base rate for FY27 subject to performance, while lifting the FY26 imputation credit rate to 30% from 25% and reinforcing its focus on steady or increasing fully franked dividends for shareholders.
The most recent analyst rating on (AU:RYD) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Ryder Capital Ltd. stock, see the AU:RYD Stock Forecast page.
Ryder Capital Ltd has announced a quarterly dividend of A$0.03 per fully paid ordinary share for the period ending 31 December 2025. The dividend will trade ex-dividend on 9 January 2026, with a record date of 12 January 2026 and payment scheduled for 27 January 2026, underscoring the company’s continued capital return to shareholders and providing income visibility for investors as the new year begins.
The most recent analyst rating on (AU:RYD) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Ryder Capital Ltd. stock, see the AU:RYD Stock Forecast page.
Ryder Capital Limited reported a pre-tax NTA increase of 3.34% in November, despite a volatile equity market. The company’s strong performance was driven by gains in Macmahon Holdings and other investments, while detractors included BCI Minerals and Fleetwood. Ryder Capital also adjusted its portfolio by increasing positions in OFX Group and Hillgrove Resources, supporting Airtasker’s capital raise, and completing its exit from Fleetwood. The company remains committed to its absolute-return, value-driven strategy, focusing on ASX-listed small/micro-caps for medium to long-term growth.
Ryder Capital Ltd. has announced an on-market buy-back of its ordinary fully paid securities, as indicated by the ASX security code RYD. This strategic move is likely aimed at optimizing capital structure and potentially enhancing shareholder value, reflecting the company’s proactive approach in managing its financial resources.
Ryder Capital Limited has announced an update on its ongoing share buy-back program. The company reported that a total of 524,839 shares have been bought back prior to December 1, 2025, with an additional 25,000 shares purchased on November 28, 2025. The highest price paid for the shares was AUD 1.75, and the lowest was AUD 1.295. Ryder Capital Limited plans to continue its buy-back initiative, with 7,560,124 shares still available for repurchase, reflecting its strategic focus on enhancing shareholder value.
Ryder Capital Limited has announced an update regarding its ongoing share buy-back program. The company, listed on the ASX under the code RYD, is actively buying back its ordinary fully paid securities, with a total of 50,000 shares repurchased on the previous day, adding to the cumulative total of 474,839 shares bought back prior. This buy-back initiative is part of Ryder Capital’s strategy to enhance shareholder value and optimize its capital structure.
Ryder Capital Ltd. reported a pre-tax NTA increase of 4.29% in October, driven by gains in core holdings such as Lumos Diagnostics and Macmahon Holdings. Despite a slight decline in BCI Minerals and a negative impact from OFX Group, the company actively managed its portfolio by adding to its Nufarm position and conducting a share buyback. The company’s strategy focuses on exceeding the RBA Cash Rate plus 4.25% through a concentrated, high-conviction portfolio of ASX-listed small/micro-caps, aiming for medium to long-term capital growth.
Ryder Capital Ltd. has announced an update on its ongoing share buy-back program. As of November 7, 2025, the company has repurchased a total of 459,839 ordinary fully paid securities, with an additional 15,000 securities bought back on the previous day. This buy-back initiative is part of Ryder Capital’s strategy to manage its capital structure and potentially enhance shareholder value.
Ryder Capital Ltd. has announced an update on its ongoing buy-back program, which involves the repurchase of its ordinary fully paid securities. As of the latest update, the company has bought back a total of 439,839 securities, with an additional 20,000 securities repurchased on the previous day. This buy-back initiative is part of Ryder Capital’s strategy to manage its capital structure and potentially enhance shareholder value.
Ryder Capital Limited has announced the cessation of 200,000 ordinary fully paid securities due to an on-market buy-back as of November 3, 2025. This move is part of the company’s capital management strategy, potentially impacting its market positioning by reducing the number of outstanding shares, which could enhance shareholder value.
Ryder Capital Ltd. has announced an update regarding its ongoing on-market buy-back program. As of October 30, 2025, the company has repurchased a total of 439,839 ordinary fully paid securities, with 8,540 bought back on the previous day. This buy-back initiative is part of Ryder Capital’s strategy to manage its capital structure and potentially enhance shareholder value.